A Study of a New LY900014 Formulation in Healthy Participants

NCT02525744 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY900014
DRUG: Insulin Lispro (Humalog)

Sponsor

Eli Lilly and Company